Resultados de la búsqueda 1251-1260 of 12481 for Vas+deferens

  1. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to compare the PFS of a standard chemotherapy approach versus an IO therapy approach (brentuximab vedotin and nivolumab) in ...

  2. Neurocirugía - Ensayos clínicos

    Rochester, Minn. The purpose of this study is to assess the differences in microvascular anastomosis outcomes between the experiment aneurysmal subarachnoid ...

  3. Neurología - Ensayos clínicos

    This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies displaying one of three different patterns ...

  4. Oncología (médica) - Ensayos clínicos

    Rochester, Minn. The purpose of this study is to evaluate thymoma recurrence rates in patients who underwent thymectomy. Effectiveness of Nurse-based Care ...

  5. Departamento de Oftalmología de Mayo Clinic - Ensayos clínicos

    The purpose of this study is to use Ultrasound surface wave elastography to measure and compare the tissue thickness and elasticity in normal eyes and eyes ...

  6. Oncología (médica) - Ensayos clínicos

    Rochester, Minn. The purpose of this study is to develop patient-derived organoid cultures of urothelial carcinoma from non-invasively obtained urine samples ...

  7. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to evaluate whether encorafenib plus cetuximab (EC), alone or in combination with chemotherapy, can improve clinical outcomes ...

  8. Ensayos clínicos - Neurocirugía

    The purpose of this study is to identify important physiologic trends in bedside ICU data such as cerebral perfusion pressure (CPP), intracranial pressure (ICP) ...

  9. Ensayos clínicos - Neurología

    VERIFY will validate biomarkers of upper extremity (UE) motor outcome in the acute ischemic stroke window for immediate use in clinical trials, and explore ...

  10. Neurología - Ensayos clínicos

    The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...